Gain Therapeutics‘ investigational STAR (small-molecule structurally targeted allosteric regulators) candidate lowered toxic amyloid-beta and tau protein levels, both hallmarks of Alzheimers disease,… [+3500 chars]
image: Computational model of gold nanoparticle functionalized with left-handed enantiomers of cysteine and phenylalanineview more Credit: André Farias de Moura Vaccines can be made over 25% more … [+5513 chars]
Inhibiting an important signaling pathway in brain-resident immune cells may calm brain inflammation and thereby slow the disease process in Alzheimers and some other neurodegenerative diseases, a st… [+4892 chars]
Systemic inflammatory biomarkers may aid in differentiating primary central nervous system lymphoma (PCNSL) from high-grade glioma (HGG), according to a study published online April 4 in CNS Oncology… [+1475 chars]
